Bausch Health executive reports tax share withholding

Bausch Health Companies Inc. reported that Aimee J. Lenar, President, US Pharma, had 5,260 Common Shares withheld on 2026-07-17 at $4.83 per share to satisfy tax withholding obligations upon vesting of Restricted Share Units.

Accepted by SEC EDGAR 07/20/2026 - 04:49 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Bausch Health Companies Inc. reported that Aimee J. Lenar, President, US Pharma, had 5,260 Common Shares withheld on 2026-07-17 at $4.83 per share to satisfy tax withholding obligations upon vesting of Restricted Share Units. After this tax-withholding disposition, she directly holds 371,680 Common Shares.

Insider Trade Summary

Tax Withholding: 5,260 shares

Tax Withholding 1 txn

Insider Lenar Aimee J.

Role President, US Pharma

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares, No Par Value F1	5,260	$4.83	$25K

Holdings After Transaction: Common Shares, No Par Value — 371,680 shares (Direct)

Holdings Before and After: Common Shares, No Par Value, 376,940 to 371,680 shares (Direct)

Footnotes (1)

1. F1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Key Figures

Shares withheld for taxes: 5260.0000 shares Price per share: $4.8300 Shares held after transaction: 371680.0000 shares +2 more

5 metrics

Shares withheld for taxes 5260.0000 shares Common Shares withheld to satisfy tax withholding obligations on 2026-07-17

Price per share $4.8300 Per-share value used for the tax-withholding disposition of Common Shares

Shares held after transaction 371680.0000 shares Direct Common Shares owned by Aimee J. Lenar following the withholding

Transaction date 2026-07-17 Date of the tax-withholding disposition of Common Shares

Tax-withholding transactions reported 1 Number of tax-withholding dispositions (code F) reported in this Form 4

Key Terms

Restricted Share Units, tax withholding obligations, Common Shares, No Par Value, exercise price or tax liability

4 terms

Restricted Share Units financial

"due upon vesting of Restricted Share Units."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

tax withholding obligations financial

"withheld to satisfy the tax withholding obligations due upon vesting"

Common Shares, No Par Value financial

"security_title: Common Shares, No Par Value"

exercise price or tax liability financial

"Payment of exercise price or tax liability by delivering securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bausch Health (BHC) report for Aimee J. Lenar?

Aimee J. Lenar reported a tax-withholding disposition of 5,260 common shares of Bausch Health. The shares were withheld on 2026-07-17 at $4.83 per share to satisfy tax obligations tied to the vesting of Restricted Share Units, not through an open-market sale.

How many Bausch Health (BHC) shares were withheld and at what price?

The filing shows 5,260 Common Shares were withheld at a value of $4.83 per share. These shares were delivered to cover tax withholding obligations arising from the vesting of Restricted Share Units, rather than being sold into the market for cash proceeds.

Why were 5,260 Bausch Health (BHC) shares disposed of in this Form 4?

The 5,260 shares were withheld to satisfy tax withholding obligations due upon vesting of Restricted Share Units. This is classified as a tax-withholding disposition (code F), where shares are delivered to cover tax liabilities instead of the insider making a separate cash payment.

How many Bausch Health (BHC) shares does Aimee J. Lenar hold after the transaction?

After the tax-withholding transaction, Aimee J. Lenar directly holds 371,680 Common Shares of Bausch Health. This post-transaction balance reflects her remaining direct ownership following the withholding of 5,260 shares to meet tax obligations on her Restricted Share Unit vesting.

Was the Bausch Health (BHC) insider transaction under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox was not selected for this transaction. That means the reported tax-withholding disposition was not identified in the filing as occurring under a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lenar Aimee J.

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, US Pharma

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	07/17/2026		F		5,260(1)	D	$4.83	371,680	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

	/s/ Brianna M. Dorsi, attorney-in-fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)